Latest Insider Transactions at Outset Medical, Inc. (OM)
This section provides a real-time view of insider transactions for Outset Medical, Inc. (OM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Outset Medical, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Outset Medical, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 01
2021
|
Martin Vazquez Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,500
+27.59%
|
$34,500
$3.88 P/Share
|
Nov 01
2021
|
D Keith Grossman Director |
SELL
Open market or private sale
|
Indirect |
3,888
-20.83%
|
$209,952
$54.66 P/Share
|
Oct 22
2021
|
Stacey L. Porter Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,499
+10.14%
|
-
|
Oct 19
2021
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
1,445
-8.76%
|
$72,250
$50.0 P/Share
|
Oct 19
2021
|
John L. Brottem General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,445
+8.06%
|
$13,005
$9.48 P/Share
|
Oct 15
2021
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
3,500
-18.87%
|
$171,500
$49.02 P/Share
|
Oct 15
2021
|
John L. Brottem General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+15.88%
|
$31,500
$9.48 P/Share
|
Oct 01
2021
|
D Keith Grossman Director |
SELL
Open market or private sale
|
Direct |
1,296
-19.69%
|
$63,504
$49.69 P/Share
|
Oct 01
2021
|
D Keith Grossman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
62
+1.82%
|
$62
$1.11 P/Share
|
Oct 01
2021
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
42,500
-5.33%
|
$2,040,000
$48.7 P/Share
|
Oct 01
2021
|
Leslie Trigg Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
42,500
+5.04%
|
$85,000
$2.93 P/Share
|
Oct 01
2021
|
Martin Vazquez Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
16,000
-36.49%
|
$768,000
$48.71 P/Share
|
Oct 01
2021
|
Martin Vazquez Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,000
+26.72%
|
$48,000
$3.88 P/Share
|
Sep 17
2021
|
D Keith Grossman Director |
SELL
Open market or private sale
|
Direct |
5,184
-28.27%
|
$285,120
$55.0 P/Share
|
Sep 17
2021
|
D Keith Grossman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,184
+22.04%
|
$5,184
$1.11 P/Share
|
Sep 17
2021
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
15,000
-5.65%
|
$825,000
$55.0 P/Share
|
Sep 17
2021
|
Leslie Trigg Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+5.35%
|
$30,000
$2.93 P/Share
|
Sep 17
2021
|
Martin Vazquez Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
13,000
-41.26%
|
$715,000
$55.0 P/Share
|
Sep 17
2021
|
Martin Vazquez Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,000
+29.21%
|
$39,000
$3.88 P/Share
|
Sep 15
2021
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
4,945
-13.82%
|
$247,250
$50.38 P/Share
|
Sep 15
2021
|
John L. Brottem General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
4,945
+11.97%
|
$44,505
$9.48 P/Share
|
Sep 07
2021
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
2,890
-8.76%
|
$144,500
$50.0 P/Share
|
Sep 07
2021
|
John L. Brottem General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,890
+8.06%
|
$26,010
$9.48 P/Share
|
Sep 01
2021
|
Martin Vazquez Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
10,000
-35.08%
|
$490,000
$49.17 P/Share
|
Sep 01
2021
|
Martin Vazquez Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+25.97%
|
$30,000
$3.88 P/Share
|
Sep 01
2021
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
20,000
-3.81%
|
$980,000
$49.16 P/Share
|
Sep 01
2021
|
Leslie Trigg Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+3.64%
|
$40,000
$2.93 P/Share
|
Sep 01
2021
|
D Keith Grossman Director |
SELL
Open market or private sale
|
Direct |
1,296
-28.27%
|
$63,504
$49.17 P/Share
|
Sep 01
2021
|
D Keith Grossman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,296
+22.04%
|
$1,296
$1.11 P/Share
|
Aug 26
2021
|
D Keith Grossman Director |
SELL
Open market or private sale
|
Direct |
1,296
-28.27%
|
$58,320
$45.0 P/Share
|
Aug 26
2021
|
D Keith Grossman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,296
+22.04%
|
$1,296
$1.11 P/Share
|
Aug 16
2021
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
3,500
-19.26%
|
$133,000
$38.68 P/Share
|
Aug 16
2021
|
John L. Brottem General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+16.15%
|
$31,500
$9.48 P/Share
|
Aug 11
2021
|
James F. Hinrichs Director |
BUY
Open market or private purchase
|
Direct |
10,000
+23.1%
|
$360,000
$36.66 P/Share
|
Aug 10
2021
|
Nabeel Ahmed Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+3.15%
|
$37,000
$37.13 P/Share
|
Aug 05
2021
|
Nabeel Ahmed Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,398
+36.53%
|
-
|
Aug 02
2021
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
20,000
-7.4%
|
$800,000
$40.62 P/Share
|
Aug 02
2021
|
Leslie Trigg Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+6.89%
|
$40,000
$2.93 P/Share
|
Aug 02
2021
|
Martin Vazquez Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,000
-35.08%
|
$200,000
$40.71 P/Share
|
Aug 02
2021
|
Martin Vazquez Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+25.97%
|
$15,000
$3.88 P/Share
|
Jul 16
2021
|
Nabeel Ahmed Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,575
+50.0%
|
-
|
Jul 15
2021
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
3,500
-19.26%
|
$150,500
$43.83 P/Share
|
Jul 15
2021
|
John L. Brottem General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+16.15%
|
$31,500
$9.48 P/Share
|
Jul 01
2021
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
42,500
-4.06%
|
$2,082,500
$49.25 P/Share
|
Jul 01
2021
|
Leslie Trigg Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
42,500
+3.89%
|
$85,000
$2.48 P/Share
|
Jul 01
2021
|
D Keith Grossman Director |
SELL
Open market or private sale
|
Direct |
1,296
-28.27%
|
$63,504
$49.23 P/Share
|
Jul 01
2021
|
D Keith Grossman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,296
+22.04%
|
$1,296
$1.11 P/Share
|
Jul 01
2021
|
Martin Vazquez Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
16,000
-36.49%
|
$784,000
$49.25 P/Share
|
Jul 01
2021
|
Martin Vazquez Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,000
+26.72%
|
$48,000
$3.88 P/Share
|
Jun 24
2021
|
Rebecca Chambers Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
16,727
-55.16%
|
$836,350
$50.72 P/Share
|